Analystreport

Denali Therapeutics Inc. (NASDAQ: DNLI) was downgraded by analysts at Cantor Fitzgerald from an "overweight" rating to a "neutral" rating.

Denali Therapeutics Inc.  (DNLI) 
Last denali therapeutics inc. earnings: 8/6 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.denalitherapeutics.com